Costan William Berard
Born: December 23, 1932, Cranford, New Jersey
Died: January 5, 2013
- AB: Princeton University, Princeton, New Jersey 1955
- MD: Harvard Medical School, Boston, Massachusetts 1959.
- 1970 - 1980 Chief, Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 1980 - 1997 Chairman, Department of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, and Professor, Department of Pathology, The University of Tennessee Center for the Health Sciences, Memphis, Tennessee.
- Strong Memorial Hospital, Rochester, New York
- Walter; Reed Army Institute of Research, Washington, D.C.
- Laboratory of Pathology, NCI, NIH, Bethesda, MD.
- 1958 - 1959 United States Army Medical Corps
- 1960 - 1963 United States Army Medical Corps
- 1963 - 1980 United States Public Health Service.
Selected Career Highlights
Graduated first in his class at Princeton University. His oratorical skills first led him to consider a career in law. However, being fascinated by biological systems, he chose instead to study medicine at Harvard Medical School and graduated Cum Laude and a member of the A.O.A.
Member, seven Editorial Boards including:
- Journal of the Reticuloendothelial Society (1972-1973)
- Laboratory Investigation
- Human Pathology
- Modern Pathology
- American Journal of Surgical Pathology.
Master ("Director of the Board") Hematopathologist at the USCAP Annual Meetings; (Moderator, Hematopathology Specialty Conferences, etc).
He worked for the establishment of The Society for Hematopathology in 1981, and served as its first President from 1982-1984. Today this society has over 700 members worldwide.
Recipient of many awards of recognition.
Director of two USCAP Long Courses (1974 and again in 1986) in Hematopathology.
As Chief of the Hematopathology Section at the NCI/NIH, he established close connections with Dr. Vincent DeVita, who was revolutionizing the treatment of malignant lymphoma and Hodgkin's disease. Dr. Berard had the foresight to see that advances in modern immunology were destined to alter forever the way in which pathologists would classify malignancies of the immune system. At the NIH he assembled a team of younger pathologists including Drs. Elaine Jaffe, Raul Braylan and Jeffrey Cossman who would pursue translational studies of malignant lymphomas utilizing the major advances from the basic sciences.
Led the multi-institutional NCI-funded study that led to the publication of the working formulation (1982). It became the most widely used classification of malignant lymphoma for clinical trials for the next decade.
Author of over 200 articles and chapters.